Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial (Q38904423)

7 September 2017

Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial (English)

1 reference

Plasmodium falciparum malaria

7 September 2017

phase II clinical trial

0 references

Mali

0 references

Plasmodium falciparum

0 references

malaria transmission

0 references

1 reference

Mikko Niemi

17

0 references

Teun Bousema

object named as

Teun Bousema

19

0 references

Alassane Dicko

1

object named as

Alassane Dicko

1 reference

7 September 2017

18

François Nosten

1 reference

7 September 2017

15

Kjerstin Lanke

1 reference

7 September 2017

11

Ingrid Chen

1 reference

7 September 2017

3

Halimatou Diawara

1 reference

7 September 2017

5

Almahamoudou Mahamar

1 reference

7 September 2017

7

Koualy Sanogo

1 reference

7 September 2017

2

Joelle M Brown

1 reference

7 September 2017

13

Jimee Hwang

1 reference

7 September 2017

20

Roly Gosling

1 reference

7 September 2017

4

Ibrahima Baber

1 reference

7 September 2017

6

Harouna M Soumare

1 reference

7 September 2017

10

Sekou F Traore

1 reference

7 September 2017

Fanta Koita

8

1 reference

7 September 2017

Sekouba Keita

9

1 reference

7 September 2017

Eugenie Poirot

12

1 reference

7 September 2017

Charles McCulloch

14

1 reference

7 September 2017

Helmi Pett

16

1 reference

7 September 2017

19 February 2016

1 reference

Lancet Infectious Diseases

7 September 2017

1 reference

7 September 2017

16

1 reference

7 September 2017

6

1 reference

7 September 2017

674-684

1 reference

The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

The changing epidemiology of malaria elimination: new strategies for new challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Strategies for detection of Plasmodium species gametocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Primaquine to prevent transmission of falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Quantification of female and male Plasmodium falciparum gametocytes by reverse transcriptase quantitative PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Asymptomatic malaria infections: detectability, transmissibility and public health relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900479-X

7 January 2021

10.1016/S1473-3099(15)00479-X

Identifiers

DOI

1 reference

7 September 2017

1 reference